A Safety and Efficacy Study of SHR-1702 Monotherapy in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia

NCT06497062 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status

NCT00462761 ·Status: COMPLETED ·Phase: PHASE1

Mitoxantrone Hydrochloride Liposome Combined With Chemotherapy in Untreated de Novo Acute Myeloid Leukemia

NCT05941585 ·Status: COMPLETED ·Phase: NA

Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients

NCT04087967 ·Status: UNKNOWN ·Phase: PHASE3

Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid Leukemia

NCT04353479 ·Status: UNKNOWN ·Phase: PHASE2

Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)

NCT00875745 ·Status: COMPLETED ·Phase: PHASE1

Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML

NCT05805098 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)

NCT00479232 ·Status: COMPLETED ·Phase: PHASE1

An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome

NCT01751867 ·Status: COMPLETED ·Phase: PHASE3

A Phase I Study of BC3402 as a Single Agent in Patients With MDS and CMML

NCT05690425 ·Status: UNKNOWN ·Phase: PHASE1

A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML)

NCT04827069 ·Status: COMPLETED ·Phase: PHASE1

A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT05687032 ·Status: COMPLETED ·Phase: PHASE4

PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML

NCT04722952 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy Study of CHG Regimen vs Decitabine to Treat Higher-risk MDS

NCT01417767 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60

NCT04083911 ·Status: UNKNOWN ·Phase: PHASE3

Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations

NCT04906031 ·Status: UNKNOWN ·Phase: PHASE2

SNS-301 Monotherapy in High Risk MDS and CMML

NCT04217720 ·Status: WITHDRAWN ·Phase: PHASE2

A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies

NCT07347171 ·Status: RECRUITING ·Phase: PHASE1

Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase

NCT00449761 ·Status: TERMINATED ·Phase: PHASE2

A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy

NCT03298516 ·Status: COMPLETED ·Phase: PHASE1

Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children

NCT05313958 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Phase I, Open-Label, Dose Escalation and Cohort Expansion Study of BS HH 002.SA in Patients With AML and MDS

NCT04743115 ·Status: UNKNOWN ·Phase: PHASE1

A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

NCT05703204 ·Status: UNKNOWN ·Phase: PHASE1

Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML

NCT05177731 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT04373395 ·Status: UNKNOWN ·Phase: NA